About
Cymantic Medical develops deep learning–based computer vision devices to provide real-time intra-procedural feedback during biopsies and tumour resections, aiming to verify procedural success and improve decision-making in surgical and interventional oncology. Its technologies are currently in pre-clinical and/or clinical development.
Explore Cymantic Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.